Company intelligence / Profile preview

Biolux Pharmaceuticals

New York, New York, USAbioluxgroup.com ↗

Ownership: Private
Employees: ~10
Development stage: Other

Overview

OrthoPulse is a commercially available, FDA-cleared medical device using near-infrared light to accelerate orthodontic tooth movement, supported by clinical studies showing up to 50% reduction in treatment time, with low device failure rates and broad adoption in the U.S. and globally.

Therapeutic areas: OtherImmunologyNeurologyDermatology
Modalities: Device (Light therapy device)Near-infrared light-accelerated orthodontic device
Industry: Therapeutic Medical Devices

Partnerships

redalpineRevere Partners

Beyond the preview

Go deeper on Biolux Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biolux Pharmaceuticals.

Explore the full profile